本页面由Tiger Trade Technology Pte. Ltd.提供服务

Acasti Pharma

3.37
0.0000
成交量:- -
成交额:9.28万
市值:3,417.13万
市盈率:-3.06
高:3.37
开:3.37
低:3.37
收:3.37
52周最高:3.60
52周最低:1.98
股本:1,013.99万
流通股本:464.64万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.1017
每股收益(LYR):-1.3488
净资产收益率:-18.56%
总资产收益率:-11.62%
市净率:0.58
市盈率(LYR):-2.50

数据加载中...

2024/10/28

重要事件披露

Form 8-K - Current report
2024/10/25

重要事件披露

Form 8-K - Current report
2024/10/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/10/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/10/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/10/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/10/08

重要事件披露

Form 8-K - Current report
2024/09/30

重要事件披露

Form 8-K - Current report
2024/09/25

重要事件披露

Form 8-K - Current report
2024/08/16

重要事件披露

Form 8-K - Current report
2024/08/09

重要事件披露

Form 8-K - Current report
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/31

SEC问询函

Form CORRESP - Correspondence
2024/07/10

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/21

重要事件披露

Form 8-K - Current report
2024/06/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/01

重要事件披露

Form 8-K - Current report
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals